Morales A, Garca-Ruiz C, Miranda M, Mari M, Colell A, Ardite E, and Fernndez-Checa JC (1997)
E.ZhangS.ChoD.-Y.GraysonJ.SkinnerD
Challenges in liver cancer and possible treatment approaches
Set contains SKU# UK200053540 C-Luma Hydrabright Serum: WATER/AQUA/EAU, PROPANEDIOL, SODIUM ASCORBYL PHOSPHATE, GLYCERIN, ISODECYL NEOPENTANOATE, SQUALANE, NEOPENTYL GLYCOL DIHEPTANOATE, C9-12 ALKANE, SODIUM POLYACRYLOYLDIMETHYL TAURATE, ASCORBYL GLUCOSIDE, COCO-CAPRYLATE/CAPRATE, SCLEROCARYA BIRREA SEED OIL, PULLULAN, SCLEROTIUM GUM, DIGLUCOSYL GALLIC ACID, SORBITAN SESQUIISOSTEARATE, GLUTATHIONE, SODIUM HYALURONATE, SORBETH-30 TETRAISOSTEARATE, DIPROPYLENE GLYCOL, PHLORETIN, SODIUM CITRATE, SODIUM METABISULFITE, PPG-8-CETETH-20, GLUCONOLACTONE, ACRYLATES/BEHENETH-25 METHACRYLATE COPOLYMER, CITRIC ACID, TETRASODIUM GLUTAMATE DIACETATE, SILICA, LECITHIN, XANTHAN GUM, TOCOPHERYL ACETATE, SODIUM HYDROXIDE, PHENOXYETHANOL, SODIUM BENZOATE, CHONDRUS CRISPUS EXTRACT
Several companies interviewed (see Chapter 5) indicated that in some cases acquisitions staff simply ignored requirements for SBIR data rights